Plus Therapeutics regains Nasdaq minimum bid price compliance after 1-for-25 reverse split

PLUS THERAPEUTICS, INC.

Nasdaq notified Plus Therapeutics on April 20, 2026 that bid price closed at or above $1.00 for 10 consecutive days through April 17.
Reverse stock split (1-for-25) was effective April 2, 2026 and enabled compliance with Listing Rule 5550(a)(2).
Nasdaq has closed the matter; PSTV common stock remains listed on The Nasdaq Capital Market.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-165205
form_type: 8-K
ticker: PSTV
cik: 0001095981
company_name: PLUS THERAPEUTICS, INC.
filed_at: 2026-04-21T23:59:59+00:00
discovered_at: 2026-05-14T18:02:31.945388+00:00
generated_at: 2026-05-15T05:03:02.249675+00:00
sec_items: ["8.01", "9.01"]
event_type: regulatory
sentiment: neutral
materiality_score: 0.3
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-165205
json_url: https://secwatch.observer/filing/0001193125-26-165205.json
markdown_url: https://secwatch.observer/filing/0001193125-26-165205.md
text_url: https://secwatch.observer/filing/0001193125-26-165205.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312526165205/0001193125-26-165205-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312526165205/pstv-20260420.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-165205

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.